Current understanding of HIV-associated neurocognitive disorders pathogenesis
- 1 June 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Neurology
- Vol. 24 (3), 275-283
- https://doi.org/10.1097/wco.0b013e32834695fb
Abstract
Purpose of review The present review discusses current concepts of HIV-associated neurocognitive disorders (HAND) in the era of antiretroviral therapy (ART). As the HIV epidemic enters its fourth decade (the second decade of ART), research must address evolving factors in HAND pathogenesis. These include persistent systemic and central nervous system (CNS) inflammation, aging in the HIV-infected brain, HIV subtype (clade) distribution, concomitant use of drugs of abuse, and potential neurotoxicity of ART drugs. Recent findings Although the severest form of HAND, HIV-associated dementia (HAD), is now rare due to ART, the persistence of milder, functionally important HAND forms persist in up to half of HIV-infected individuals. HAND prevalence may be higher in areas of Africa where different HIV subtypes predominate, and ART regimens that are more effective in suppressing CNS HIV replication can improve neurological outcomes. HAND are correlated with persistent systemic and CNS inflammation, and enhanced neuronal injury due to stimulant abuse (cocaine and methamphetamine), aging, and possibly ART drugs themselves. Summary Prevention and treatment of HAND requires strategies aimed at suppressing CNS HIV replication and effects of systemic and CNS inflammation in aging and substance-abusing HIV populations. Use of improved CNS-penetrating ART must be accompanied by evaluation of potential ART neurotoxicity.Keywords
This publication has 157 references indexed in Scilit:
- Pathogenesis of HIV in the Central Nervous SystemCurrent HIV/AIDS Reports, 2010
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsJournal of NeuroVirology, 2010
- Morphine treatment of human monocyte‐derived macrophages induces differential miRNA and protein expression: Impact on inflammation and oxidative stress in the central nervous systemJournal of Cellular Biochemistry, 2010
- Lipoprotein particle subclasses, cardiovascular disease and HIV infectionAtherosclerosis, 2009
- Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected PatientsJournal of Neuroimmune Pharmacology, 2009
- The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART EraJournal of Neuroimmune Pharmacology, 2008
- Greater Than Age-Related Changes in Brain Diffusion of HIV Patients After 1 YearJournal of Neuroimmune Pharmacology, 2008
- Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuseBrain Research, 2008
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA)Brain Research, 2006